February 4 is World Cancer Day in Blog Posts


Everyday researchers around the world look for new therapies in hopes to shape the future of cancer treatments
in the forthcoming years. From novel chemotherapies to immunotherapies, targeted therapies, and combination
therapies, the race for a cure holds a promise for many struggling with the disease.

Eight million people die from cancer worldwide every year, out of which four million people die prematurely
(aged 30 to 69 years). Leading cancer risk factors include tobacco, alcohol, environmental, diet, physical inactivity,
cancer-causing infections.

Among the most exciting new treatments are immunotherapies, which use the patients’ immune system to battle
the disease. A central player in cancer immunotherapies is a white blood cell known as the T cell, which in healthy
individuals identifies and kills infected or abnormal cells, including cancer cells. Through genetic engineering, biotech
companies activate a patients’ own T cells so that they attack cancer cells.

Honoring International Researchers on World Cancer Day

Every year on February 4, World Cancer Day unites the world’s population in the fight against cancer by raising
awareness and education about the disease, in hope that millions can be saved.

Quick is proud to be a partner with these innovative healthcare companies who take aim every day to erase cancer
in our lifetime.

Let’s spread the word on this global event day and raise the profile of cancer in people’s minds and in the world’s media.
Show the world that we can get involved in the fight against cancer.

World Cancer Day -- make a difference to the fight against cancer.

Discover how to get engaged:http://www.worldcancerday.org

About the author

VP Marketing
As Vice President of Marketing for the Quick Group of Companies worldwide, Marie manages all company and client communications, corporate identity, public relations, brand development, corporate websites, online and... Read more.
To submit comments please login or create your account .

We are
Join us.